Lataa...
Vilazodone for the Treatment of Depression: An Update
Vilazodone is a novel antidepressant having a selective serotonin (5-HT) reuptake inhibitor and 5-HT1A receptor partial agonist profile, so it has been regarded as a serotonin partial agonist-reuptake inhibitor (SPARI). We aimed to provide Vilazodone's clinical implications mainly by reviewing...
Tallennettuna:
| Julkaisussa: | Chonnam Med J |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Chonnam National University Medical School
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4880584/ https://ncbi.nlm.nih.gov/pubmed/27231672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2016.52.2.91 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|